In prostate cancer, T-box2 (TBX2) was found to promote the transcription of Wnt3a, which, together with the Wnt effector TCF4, is highly overexpressed in osteoblastic bone metastasis [132]. This evidence concerns the gene WNT3A and prostate carcinoma.